IN8bio progresses its novel approach to cancer therapy with

IN8bio (NASDAQ:INAB) chief financial officer Patrick McCall takes Proactive's Stephen Gunnion through the clinical-stage biopharmaceutical...

Related Keywords

Patrick Mccall , Stephen Gunnion , Dunbar Car Program , University Of Louisville , Nasdaq , Cell Program ,